177lu-psma-617,pembrolizumab
merck,novartis
['psma-617 ', '177lu,psma,617', 'prostate', 'pembro']
a phase 1b study of a single priming dose of 177lu-psma-617 coupled with pembrolizumab in metastatic castration-resistant #prostatecancer. presentation by rahul aggarwal, md . #esmo22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology